Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Applied Therapeutics: Q3 Earnings Insights

Applied Therapeutics (NASDAQ:APLT) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:30 AM. Here’s what…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Applied Therapeutics (NASDAQ:APLT) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Applied Therapeutics missed estimated earnings by 80.77%, reporting an EPS of $-0.47 versus an estimate of $-0.26.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 3.82% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Applied Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Is Energy Company EQT Stock Sliding Today?

By Lekha Gupta
February 14, 9:35 AM
EQT Corp reports Q4 FY24 revenue of $1.549 billion, below consensus, with adjusted EPS of $0.48 missing expectations. Production reaches 564 Bcfe, driven by operational efficiency gains, but the average realized price dips to $2.75/Mcfe. With 2024 sales volume projections of 2,200 – 2,300 Bcfe and strategic capex plans, EQT navigates midstream constraints, eyeing growth amidst industry shifts.

EQT